Transcend Therapeutics and Yale awarded U.S. Department of Defense grant to study methylone for PTSD

Transcend Therapeutics, a mental health-focused biotechnology company, announces Series A funding round of $40 million led by Alpha Wave Global and Integrated Investment Partners